HEADER LIPID BINDING PROTEIN 16-APR-09 3H3I TITLE CRYSTAL STRUCTURE OF A PUTATIVE LIPID BINDING PROTEIN (BT_2261) FROM TITLE 2 BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 2.20 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE LIPID BINDING PROTEIN; COMPND 3 CHAIN: A, B, C; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACTEROIDES THETAIOTAOMICRON VPI-5482; SOURCE 3 ORGANISM_TAXID: 226186; SOURCE 4 GENE: BT_2261, NP_811174.1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, KEYWDS 2 PROTEIN STRUCTURE INITIATIVE, PSI-2, LIPID BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 7 01-FEB-23 3H3I 1 REMARK SEQADV REVDAT 6 24-JUL-19 3H3I 1 REMARK LINK REVDAT 5 01-NOV-17 3H3I 1 REMARK REVDAT 4 13-JUL-11 3H3I 1 VERSN REVDAT 3 28-JUL-10 3H3I 1 TITLE KEYWDS REVDAT 2 24-NOV-09 3H3I 1 TITLE REVDAT 1 28-APR-09 3H3I 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF PUTATIVE LIPID BINDING PROTEIN JRNL TITL 2 (NP_811174.1) FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT JRNL TITL 3 2.20 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0053 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.60 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 24985 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1272 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1747 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.78 REMARK 3 BIN R VALUE (WORKING SET) : 0.2440 REMARK 3 BIN FREE R VALUE SET COUNT : 89 REMARK 3 BIN FREE R VALUE : 0.3150 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3209 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 204 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 39.66 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.71 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.69000 REMARK 3 B22 (A**2) : 0.69000 REMARK 3 B33 (A**2) : -1.03000 REMARK 3 B12 (A**2) : 0.34000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.250 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.200 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.145 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.824 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3356 ; 0.011 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2098 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4590 ; 1.495 ; 1.929 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5117 ; 0.849 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 425 ; 3.669 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 164 ;30.216 ;25.244 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 491 ;10.546 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 9 ; 9.815 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 495 ; 0.093 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3846 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 715 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2070 ; 0.871 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 853 ; 0.155 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3332 ; 1.749 ; 4.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1286 ; 3.200 ; 6.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1251 ; 4.534 ; 8.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B C REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 29 A 166 6 REMARK 3 1 B 29 B 166 6 REMARK 3 1 C 29 C 166 6 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 LOOSE POSITIONAL 1 A (A): 1680 ; 0.210 ; 5.000 REMARK 3 LOOSE POSITIONAL 1 B (A): 1680 ; 0.220 ; 5.000 REMARK 3 LOOSE POSITIONAL 1 C (A): 1680 ; 0.260 ; 5.000 REMARK 3 LOOSE THERMAL 1 A (A**2): 1680 ; 2.770 ;10.000 REMARK 3 LOOSE THERMAL 1 B (A**2): 1680 ; 1.900 ;10.000 REMARK 3 LOOSE THERMAL 1 C (A**2): 1680 ; 2.060 ;10.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 29 A 166 REMARK 3 ORIGIN FOR THE GROUP (A): 11.6870 60.5308 50.0551 REMARK 3 T TENSOR REMARK 3 T11: 0.3888 T22: 0.2827 REMARK 3 T33: 0.2212 T12: 0.3075 REMARK 3 T13: -0.1621 T23: -0.1361 REMARK 3 L TENSOR REMARK 3 L11: 1.8678 L22: 2.7673 REMARK 3 L33: 3.0074 L12: 0.7453 REMARK 3 L13: 0.4870 L23: 0.7387 REMARK 3 S TENSOR REMARK 3 S11: 0.2824 S12: 0.0743 S13: -0.2830 REMARK 3 S21: -0.0009 S22: 0.0120 S23: -0.0738 REMARK 3 S31: 0.9591 S32: 0.7168 S33: -0.2944 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 29 B 166 REMARK 3 ORIGIN FOR THE GROUP (A): -15.4494 63.0073 29.6397 REMARK 3 T TENSOR REMARK 3 T11: 0.3907 T22: 0.0655 REMARK 3 T33: 0.1588 T12: -0.1238 REMARK 3 T13: -0.0018 T23: -0.0415 REMARK 3 L TENSOR REMARK 3 L11: 2.9543 L22: 1.8570 REMARK 3 L33: 3.4274 L12: 0.3519 REMARK 3 L13: 0.6764 L23: 0.8858 REMARK 3 S TENSOR REMARK 3 S11: 0.1030 S12: 0.0279 S13: 0.2708 REMARK 3 S21: 0.3842 S22: -0.1025 S23: 0.1255 REMARK 3 S31: 0.9180 S32: -0.1845 S33: -0.0005 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 29 C 166 REMARK 3 ORIGIN FOR THE GROUP (A): -18.9267 86.8603 53.5985 REMARK 3 T TENSOR REMARK 3 T11: 0.0755 T22: 0.1424 REMARK 3 T33: 0.1496 T12: 0.0505 REMARK 3 T13: 0.0324 T23: -0.0570 REMARK 3 L TENSOR REMARK 3 L11: 5.2466 L22: 1.7295 REMARK 3 L33: 4.3333 L12: 1.7671 REMARK 3 L13: 0.3075 L23: 0.0976 REMARK 3 S TENSOR REMARK 3 S11: -0.0443 S12: -0.2948 S13: 0.2062 REMARK 3 S21: -0.1993 S22: -0.0135 S23: -0.0260 REMARK 3 S31: -0.3722 S32: -0.6730 S33: 0.0578 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1.HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. 2.ATOM RECORDS CONTAIN RESIDUAL B FACTORS REMARK 3 ONLY. 3.A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE REMARK 3 ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 FOR THE REDUCED REMARK 3 SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION. 4.SULFATES REMARK 3 (SO4) FROM THE CRYSTALLIZATION CONDITION HAVE BEEN MODELED IN REMARK 3 THE SOLVENT STRUCTURE. REMARK 4 REMARK 4 3H3I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-APR-09. REMARK 100 THE DEPOSITION ID IS D_1000052645. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837,0.97895,0.97833 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 MONOCHROMATOR (HORIZONTAL REMARK 200 FOCUSING) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA 3.2.5 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25038 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 29.604 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.500 REMARK 200 R MERGE (I) : 0.08300 REMARK 200 R SYM (I) : 0.08300 REMARK 200 FOR THE DATA SET : 7.0780 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.26 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.50 REMARK 200 R MERGE FOR SHELL (I) : 0.59000 REMARK 200 R SYM FOR SHELL (I) : 0.59000 REMARK 200 FOR SHELL : 1.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.5000M (NH4)2SO4, 1.0000M LI2SO4, REMARK 280 0.1M CITRATE PH 5.6, NANODROP, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 1 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -Y,-X,-Z+1/3 REMARK 290 5555 -X+Y,Y,-Z+2/3 REMARK 290 6555 X,X-Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 124.10933 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 62.05467 REMARK 290 SMTRY1 4 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 62.05467 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 124.10933 REMARK 290 SMTRY1 6 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 ALA A 18 REMARK 465 CYS A 19 REMARK 465 ASP A 20 REMARK 465 ASN A 21 REMARK 465 ASP A 22 REMARK 465 THR A 23 REMARK 465 GLU A 24 REMARK 465 PRO A 25 REMARK 465 GLY A 26 REMARK 465 GLY A 27 REMARK 465 THR A 28 REMARK 465 GLY B 0 REMARK 465 ALA B 18 REMARK 465 CYS B 19 REMARK 465 ASP B 20 REMARK 465 ASN B 21 REMARK 465 ASP B 22 REMARK 465 THR B 23 REMARK 465 GLU B 24 REMARK 465 PRO B 25 REMARK 465 GLY B 26 REMARK 465 GLY B 27 REMARK 465 THR B 28 REMARK 465 GLY C 0 REMARK 465 ALA C 18 REMARK 465 CYS C 19 REMARK 465 ASP C 20 REMARK 465 ASN C 21 REMARK 465 ASP C 22 REMARK 465 THR C 23 REMARK 465 GLU C 24 REMARK 465 PRO C 25 REMARK 465 GLY C 26 REMARK 465 GLY C 27 REMARK 465 THR C 28 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 31 CG CD OE1 OE2 REMARK 470 LYS A 32 CG CD CE NZ REMARK 470 LYS A 48 CG CD CE NZ REMARK 470 LYS A 112 CE NZ REMARK 470 LYS A 114 NZ REMARK 470 LYS A 119 CG CD CE NZ REMARK 470 GLU B 31 CG CD OE1 OE2 REMARK 470 LYS B 32 CG CD CE NZ REMARK 470 LYS B 48 CG CD CE NZ REMARK 470 GLU B 110 CG CD OE1 OE2 REMARK 470 LYS B 114 NZ REMARK 470 LYS B 119 CD CE NZ REMARK 470 GLU C 31 CG CD OE1 OE2 REMARK 470 LYS C 32 CG CD CE NZ REMARK 470 LYS C 48 CG CD CE NZ REMARK 470 GLU C 71 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG C 96 NE - CZ - NH1 ANGL. DEV. = 3.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 52 61.97 38.33 REMARK 500 PHE A 82 -90.31 -126.43 REMARK 500 GLU A 84 74.45 66.48 REMARK 500 GLU A 84 69.63 71.85 REMARK 500 GLU A 110 98.96 -65.47 REMARK 500 GLU B 31 -82.37 -12.02 REMARK 500 ASP B 52 64.36 24.59 REMARK 500 PHE B 82 -83.68 -123.87 REMARK 500 GLU B 84 71.63 76.93 REMARK 500 GLU C 31 -66.82 -29.02 REMARK 500 ASP C 52 63.47 34.55 REMARK 500 PHE C 82 -94.86 -122.71 REMARK 500 GLU C 84 75.05 77.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 5 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 3 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 6 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 393040 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CLONED CONSTRUCT INCLUDING RESIDUES 18-166 WAS EXPRESSED WITH A REMARK 999 PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV REMARK 999 PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3H3I A 18 166 UNP Q8A5H8 Q8A5H8_BACTN 18 166 DBREF 3H3I B 18 166 UNP Q8A5H8 Q8A5H8_BACTN 18 166 DBREF 3H3I C 18 166 UNP Q8A5H8 Q8A5H8_BACTN 18 166 SEQADV 3H3I GLY A 0 UNP Q8A5H8 EXPRESSION TAG SEQADV 3H3I GLY B 0 UNP Q8A5H8 EXPRESSION TAG SEQADV 3H3I GLY C 0 UNP Q8A5H8 EXPRESSION TAG SEQRES 1 A 150 GLY ALA CYS ASP ASN ASP THR GLU PRO GLY GLY THR ALA SEQRES 2 A 150 VAL GLU LYS MSE ALA GLY ASP TRP TRP VAL THR VAL ASN SEQRES 3 A 150 ALA PHE ILE ASP GLY LYS GLU VAL GLU ASP PRO PHE GLY SEQRES 4 A 150 ALA GLY HIS LEU GLN MSE SER THR TYR ASN THR ALA SER SEQRES 5 A 150 ASN SER GLU THR GLU MSE TRP LEU ASP ASP LEU GLY ASN SEQRES 6 A 150 PHE TRP GLU TYR LYS LEU LYS VAL ASN VAL ASN TYR ALA SEQRES 7 A 150 ALA ARG THR PHE SER THR THR GLY PHE VAL ASP ASN VAL SEQRES 8 A 150 THR TYR GLU SER LYS VAL LYS ILE THR ASP GLY LYS VAL SEQRES 9 A 150 LEU GLU LYS ALA ALA THR THR PRO SER GLY MSE PRO ALA SEQRES 10 A 150 ASP SER ILE VAL TYR MSE VAL GLN PHE ASP ASP ASP GLU SEQRES 11 A 150 ASP GLY LEU THR TYR LYS VAL SER GLY PHE ARG ARG THR SEQRES 12 A 150 GLY PHE PRO ALA ASP ASP PHE SEQRES 1 B 150 GLY ALA CYS ASP ASN ASP THR GLU PRO GLY GLY THR ALA SEQRES 2 B 150 VAL GLU LYS MSE ALA GLY ASP TRP TRP VAL THR VAL ASN SEQRES 3 B 150 ALA PHE ILE ASP GLY LYS GLU VAL GLU ASP PRO PHE GLY SEQRES 4 B 150 ALA GLY HIS LEU GLN MSE SER THR TYR ASN THR ALA SER SEQRES 5 B 150 ASN SER GLU THR GLU MSE TRP LEU ASP ASP LEU GLY ASN SEQRES 6 B 150 PHE TRP GLU TYR LYS LEU LYS VAL ASN VAL ASN TYR ALA SEQRES 7 B 150 ALA ARG THR PHE SER THR THR GLY PHE VAL ASP ASN VAL SEQRES 8 B 150 THR TYR GLU SER LYS VAL LYS ILE THR ASP GLY LYS VAL SEQRES 9 B 150 LEU GLU LYS ALA ALA THR THR PRO SER GLY MSE PRO ALA SEQRES 10 B 150 ASP SER ILE VAL TYR MSE VAL GLN PHE ASP ASP ASP GLU SEQRES 11 B 150 ASP GLY LEU THR TYR LYS VAL SER GLY PHE ARG ARG THR SEQRES 12 B 150 GLY PHE PRO ALA ASP ASP PHE SEQRES 1 C 150 GLY ALA CYS ASP ASN ASP THR GLU PRO GLY GLY THR ALA SEQRES 2 C 150 VAL GLU LYS MSE ALA GLY ASP TRP TRP VAL THR VAL ASN SEQRES 3 C 150 ALA PHE ILE ASP GLY LYS GLU VAL GLU ASP PRO PHE GLY SEQRES 4 C 150 ALA GLY HIS LEU GLN MSE SER THR TYR ASN THR ALA SER SEQRES 5 C 150 ASN SER GLU THR GLU MSE TRP LEU ASP ASP LEU GLY ASN SEQRES 6 C 150 PHE TRP GLU TYR LYS LEU LYS VAL ASN VAL ASN TYR ALA SEQRES 7 C 150 ALA ARG THR PHE SER THR THR GLY PHE VAL ASP ASN VAL SEQRES 8 C 150 THR TYR GLU SER LYS VAL LYS ILE THR ASP GLY LYS VAL SEQRES 9 C 150 LEU GLU LYS ALA ALA THR THR PRO SER GLY MSE PRO ALA SEQRES 10 C 150 ASP SER ILE VAL TYR MSE VAL GLN PHE ASP ASP ASP GLU SEQRES 11 C 150 ASP GLY LEU THR TYR LYS VAL SER GLY PHE ARG ARG THR SEQRES 12 C 150 GLY PHE PRO ALA ASP ASP PHE MODRES 3H3I MSE A 33 MET SELENOMETHIONINE MODRES 3H3I MSE A 61 MET SELENOMETHIONINE MODRES 3H3I MSE A 74 MET SELENOMETHIONINE MODRES 3H3I MSE A 131 MET SELENOMETHIONINE MODRES 3H3I MSE A 139 MET SELENOMETHIONINE MODRES 3H3I MSE B 33 MET SELENOMETHIONINE MODRES 3H3I MSE B 61 MET SELENOMETHIONINE MODRES 3H3I MSE B 74 MET SELENOMETHIONINE MODRES 3H3I MSE B 131 MET SELENOMETHIONINE MODRES 3H3I MSE B 139 MET SELENOMETHIONINE MODRES 3H3I MSE C 33 MET SELENOMETHIONINE MODRES 3H3I MSE C 61 MET SELENOMETHIONINE MODRES 3H3I MSE C 74 MET SELENOMETHIONINE MODRES 3H3I MSE C 131 MET SELENOMETHIONINE MODRES 3H3I MSE C 139 MET SELENOMETHIONINE HET MSE A 33 8 HET MSE A 61 8 HET MSE A 74 8 HET MSE A 131 8 HET MSE A 139 8 HET MSE B 33 8 HET MSE B 61 8 HET MSE B 74 8 HET MSE B 131 8 HET MSE B 139 8 HET MSE C 33 8 HET MSE C 61 8 HET MSE C 74 8 HET MSE C 131 13 HET MSE C 139 8 HET SO4 A 1 5 HET SO4 B 2 5 HET SO4 B 5 5 HET SO4 C 3 5 HET SO4 C 4 5 HET SO4 C 6 5 HETNAM MSE SELENOMETHIONINE HETNAM SO4 SULFATE ION FORMUL 1 MSE 15(C5 H11 N O2 SE) FORMUL 4 SO4 6(O4 S 2-) FORMUL 10 HOH *204(H2 O) HELIX 1 1 VAL A 30 ALA A 34 5 5 HELIX 2 2 PHE A 161 ASP A 165 5 5 HELIX 3 3 VAL B 30 ALA B 34 5 5 HELIX 4 4 PHE B 161 ASP B 165 5 5 HELIX 5 5 VAL C 30 ALA C 34 5 5 HELIX 6 6 PHE C 161 ASP C 165 5 5 SHEET 1 A 8 LYS A 48 VAL A 50 0 SHEET 2 A 8 GLY A 35 ILE A 45 -1 N ALA A 43 O VAL A 50 SHEET 3 A 8 LEU A 59 ASN A 65 -1 O THR A 63 N GLY A 35 SHEET 4 A 8 GLU A 73 ASP A 77 -1 O TRP A 75 N TYR A 64 SHEET 5 A 8 LYS A 86 ASN A 92 -1 O VAL A 89 N MSE A 74 SHEET 6 A 8 THR A 97 SER A 99 -1 O SER A 99 N ASN A 90 SHEET 7 A 8 LYS A 112 THR A 126 -1 O GLY A 118 N PHE A 98 SHEET 8 A 8 VAL A 104 ASP A 105 -1 N VAL A 104 O VAL A 113 SHEET 1 B 6 LYS A 48 VAL A 50 0 SHEET 2 B 6 GLY A 35 ILE A 45 -1 N ALA A 43 O VAL A 50 SHEET 3 B 6 TYR A 151 ARG A 157 -1 O LYS A 152 N ASN A 42 SHEET 4 B 6 PRO A 132 PHE A 142 -1 N TYR A 138 O VAL A 153 SHEET 5 B 6 LYS A 112 THR A 126 -1 N LEU A 121 O SER A 135 SHEET 6 B 6 VAL A 104 ASP A 105 -1 N VAL A 104 O VAL A 113 SHEET 1 C 8 LYS B 48 VAL B 50 0 SHEET 2 C 8 GLY B 35 ILE B 45 -1 N ALA B 43 O VAL B 50 SHEET 3 C 8 LEU B 59 TYR B 64 -1 O LEU B 59 N VAL B 39 SHEET 4 C 8 GLU B 73 ASP B 77 -1 O TRP B 75 N TYR B 64 SHEET 5 C 8 LYS B 86 ASN B 92 -1 O LEU B 87 N LEU B 76 SHEET 6 C 8 THR B 97 SER B 99 -1 O SER B 99 N ASN B 90 SHEET 7 C 8 LYS B 112 THR B 126 -1 O GLY B 118 N PHE B 98 SHEET 8 C 8 VAL B 104 ASP B 105 -1 N VAL B 104 O VAL B 113 SHEET 1 D 6 LYS B 48 VAL B 50 0 SHEET 2 D 6 GLY B 35 ILE B 45 -1 N ALA B 43 O VAL B 50 SHEET 3 D 6 THR B 150 ARG B 157 -1 O LYS B 152 N ASN B 42 SHEET 4 D 6 PRO B 132 PHE B 142 -1 N VAL B 140 O TYR B 151 SHEET 5 D 6 LYS B 112 THR B 126 -1 N LEU B 121 O SER B 135 SHEET 6 D 6 VAL B 104 ASP B 105 -1 N VAL B 104 O VAL B 113 SHEET 1 E 8 LYS C 48 VAL C 50 0 SHEET 2 E 8 GLY C 35 ILE C 45 -1 N ALA C 43 O VAL C 50 SHEET 3 E 8 LEU C 59 ASN C 65 -1 O LEU C 59 N VAL C 39 SHEET 4 E 8 GLU C 73 ASP C 77 -1 O TRP C 75 N TYR C 64 SHEET 5 E 8 LYS C 86 ASN C 92 -1 O VAL C 89 N MSE C 74 SHEET 6 E 8 THR C 97 SER C 99 -1 O SER C 99 N ASN C 90 SHEET 7 E 8 LYS C 112 THR C 126 -1 O GLY C 118 N PHE C 98 SHEET 8 E 8 VAL C 104 ASP C 105 -1 N VAL C 104 O VAL C 113 SHEET 1 F 6 LYS C 48 VAL C 50 0 SHEET 2 F 6 GLY C 35 ILE C 45 -1 N ALA C 43 O VAL C 50 SHEET 3 F 6 TYR C 151 ARG C 157 -1 O PHE C 156 N TRP C 38 SHEET 4 F 6 PRO C 132 PHE C 142 -1 N VAL C 140 O TYR C 151 SHEET 5 F 6 LYS C 112 THR C 126 -1 N ALA C 125 O ALA C 133 SHEET 6 F 6 VAL C 104 ASP C 105 -1 N VAL C 104 O VAL C 113 LINK C LYS A 32 N MSE A 33 1555 1555 1.33 LINK C MSE A 33 N ALA A 34 1555 1555 1.33 LINK C GLN A 60 N MSE A 61 1555 1555 1.33 LINK C MSE A 61 N SER A 62 1555 1555 1.33 LINK C GLU A 73 N MSE A 74 1555 1555 1.33 LINK C MSE A 74 N TRP A 75 1555 1555 1.33 LINK C GLY A 130 N MSE A 131 1555 1555 1.33 LINK C MSE A 131 N PRO A 132 1555 1555 1.34 LINK C TYR A 138 N MSE A 139 1555 1555 1.33 LINK C MSE A 139 N VAL A 140 1555 1555 1.34 LINK C LYS B 32 N MSE B 33 1555 1555 1.33 LINK C MSE B 33 N ALA B 34 1555 1555 1.33 LINK C GLN B 60 N MSE B 61 1555 1555 1.33 LINK C MSE B 61 N SER B 62 1555 1555 1.33 LINK C GLU B 73 N MSE B 74 1555 1555 1.33 LINK C MSE B 74 N TRP B 75 1555 1555 1.32 LINK C GLY B 130 N MSE B 131 1555 1555 1.32 LINK C MSE B 131 N PRO B 132 1555 1555 1.34 LINK C TYR B 138 N MSE B 139 1555 1555 1.33 LINK C MSE B 139 N VAL B 140 1555 1555 1.33 LINK C LYS C 32 N MSE C 33 1555 1555 1.33 LINK C MSE C 33 N ALA C 34 1555 1555 1.32 LINK C GLN C 60 N MSE C 61 1555 1555 1.32 LINK C MSE C 61 N SER C 62 1555 1555 1.33 LINK C GLU C 73 N MSE C 74 1555 1555 1.35 LINK C MSE C 74 N TRP C 75 1555 1555 1.33 LINK C GLY C 130 N MSE C 131 1555 1555 1.32 LINK C MSE C 131 N PRO C 132 1555 1555 1.34 LINK C TYR C 138 N MSE C 139 1555 1555 1.32 LINK C MSE C 139 N VAL C 140 1555 1555 1.32 SITE 1 AC1 3 GLY A 57 HIS A 58 HOH A 196 SITE 1 AC2 4 GLY B 57 HIS B 58 HOH B 215 HOH B 216 SITE 1 AC3 2 ARG B 158 GLY B 160 SITE 1 AC4 3 HIS C 58 HOH C 205 HOH C 245 SITE 1 AC5 2 LYS C 114 GLN C 141 SITE 1 AC6 3 HIS C 58 HOH C 233 HOH C 238 CRYST1 67.383 67.383 186.164 90.00 90.00 120.00 P 32 1 2 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014841 0.008568 0.000000 0.00000 SCALE2 0.000000 0.017136 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005372 0.00000